Neurosense Therapeutics Ltd.'s total assets for Q2 2025 were $1.68M, a decrease of -63.19% from the previous quarter. NRSN total liabilities were $2.20M for the fiscal quarter, a 10.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.